MADRIGAL PHARMACEUTICALS, INC.·4

Jan 20, 5:46 PM ET

Taub Rebecca 4

4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Jan 20, 2026

Insider Transaction Report

Form 4
Period: 2026-01-20
Taub Rebecca
Director
Transactions
  • Sale

    Common Stock

    [F1]
    2026-01-20$490.77/sh2,238$1,098,343453,351 total
Holdings
  • Common Stock

    [F2]
    (indirect: By LLC)
    655,540
Footnotes (2)
  • [F1]This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
  • [F2]The Reporting Person and her spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Mardi Dier, as Attorney-in-Fact|2026-01-20

Documents

1 file
  • 4
    wk-form4_1768949160.xmlPrimary

    FORM 4